[Tissue polypeptide antigen (TPA) and plasma TPA levels during the postoperative course in female primary breast carcinoma patients. 1st results of a long-term study].
TPA determinations can be used for monitoring advanced cancer patients. Increasing and decreasing TPA levels can be correlated to the further course of the disease. TPA levels should be determined in the postoperative follow-up of cancer patients with a higher risk of recurrence. Single point determinations for primary diagnosis is not recommended. Only the interpretation of long term evaluation studies in combination with clinical findings can be an advantage in managing cancer patients.
Mross
K
K
Wolfrum
I
I
Rauschecker
H
H
D002293:Adenocarcinoma, Scirrhous / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis*; D001943:Breast Neoplasms / Q000276:immunology* / Q000601:surgery; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002277:Carcinoma / Q000276:immunology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy; D009367:Neoplasm Staging; D010455:Peptides / Q000032:analysis*; D013724:Teratoma / Q000276:immunology; D019396:Tissue Polypeptide Antigen
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen
Ergebnisse mit dem Tissue Polypeptide Antigen (TPA) und Plasma-TPA-Werte im postoperativen Verlauf bei primären Mammakarzinompatientinnen. Erste Ergebnisse einer Langzeitstudie.